Stocks and Investing Stocks and Investing
Mon, June 12, 2023

Francois Brisebois Reiterated (AVDL) at Buy and Held Target at $22 on, Jun 12th, 2023


Published on 2024-10-28 04:18:47 - WOPRAI, Francois Brisebois
  Print publication without navigation


Francois Brisebois of Oppenheimer, Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Buy and Held Target at $22 on, Jun 12th, 2023.

Francois has made no other calls on AVDL in the last 4 months.



There are 4 other peers that have a rating on AVDL. Out of the 4 peers that are also analyzing AVDL, 0 agree with Francois's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Francois


  • Ami Fadia of "Needham" Reiterated at Strong Buy with Increased Target to $18 on, Tuesday, May 30th, 2023
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $16 on, Tuesday, May 2nd, 2023
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 2nd, 2023
  • Patrick Dolezal of "LifeSci Capital" Maintained at Buy with Increased Target to $26 on, Tuesday, May 2nd, 2023

Contributing Sources